Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.
Gyurkocza B, Cao TM, Storb RF, Lange T, Leisenring W, Franke GN, Sorror M, Hoppe R, Maloney DG, Negrin RS, Shizuru JA, Sandmaier BM. Gyurkocza B, et al. Among authors: leisenring w. Biol Blood Marrow Transplant. 2009 Oct;15(10):1314-22. doi: 10.1016/j.bbmt.2009.06.011. Epub 2009 Aug 3. Biol Blood Marrow Transplant. 2009. PMID: 19747640 Free PMC article.
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
Furlong T, Leisenring W, Storb R, Anasetti C, Appelbaum FR, Carpenter PA, Deeg HJ, Doney K, Kiem HP, Nash RA, Sanders JE, Witherspoon R, Thompson D, Martin PJ. Furlong T, et al. Among authors: leisenring w. Biol Blood Marrow Transplant. 2002;8(4):206-12. doi: 10.1053/bbmt.2002.v8.pm12014809. Biol Blood Marrow Transplant. 2002. PMID: 12014809 Free article.
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.
Mielcarek M, Burroughs L, Leisenring W, Diaconescu R, Martin PJ, Sandmaier BM, Maloney DG, Maris MB, Chauncey TR, Shizuru JA, Blume KG, Hegenbart U, Niederwieser D, Forman S, Bruno B, Woolfrey A, Storb R. Mielcarek M, et al. Among authors: leisenring w. Br J Haematol. 2005 May;129(3):381-91. doi: 10.1111/j.1365-2141.2005.05458.x. Br J Haematol. 2005. PMID: 15842663 Free article.
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
Burroughs L, Mielcarek M, Leisenring W, Sandmaier BM, Maloney DG, Baron F, Martin PJ, Flowers ME, Forman SJ, Chauncey TR, Bruno B, Storb R. Burroughs L, et al. Among authors: leisenring w. Transplantation. 2006 Mar 27;81(6):818-25. doi: 10.1097/01.tp.0000203556.06145.5b. Transplantation. 2006. PMID: 16570002 Free article.
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Carnevale-Schianca F, Leisenring W, Martin PJ, Furlong T, Schoch G, Anasetti C, Appelbaum FR, Carpenter PA, Deeg HJ, Kiem HP, Storb R, McDonald GB, Nash RA. Carnevale-Schianca F, et al. Among authors: leisenring w. Biol Blood Marrow Transplant. 2009 Jun;15(6):749-56. doi: 10.1016/j.bbmt.2009.03.009. Biol Blood Marrow Transplant. 2009. PMID: 19450760 Free PMC article.
475 results